-
1Academic Journal
المؤلفون: Pollock, KM, Borges, AH, Cheeseman, HM, Rosenkrands, I, Schmidt, KL, Søndergaard, RE, Day, S, Evans, A, McFarlane, LR, Joypooranachandran, J, Amini, F, Skallerup, P, Dohn, RB, Jensen, CG, Olsen, AW, Bang, P, Cole, T, Schronce, J, Lemm, N-M, Kristiansen, MP, Andersen, PL, Dietrich, J, Shattock, RJ, Follmann, F
Relation: https://ora.ox.ac.uk/objects/uuid:96218dc7-fa43-4549-9ba2-e3cd919f3aea; https://doi.org/10.1016/S1473-3099(24)00147-6
-
2Academic Journal
المؤلفون: Szubert, AJ, Pollock, KM, Cheeseman, HM, Alagaratnam, J, Bern, H, Bird, O, Boffito, M, Byrne, R, Cole, T, Cosgrove, CA, Faust, SN, Fidler, S, Galiza, E, Hassanin, H, Kalyan, M, Libri, V, McFarlane, LR, Milinkovic, A, O'Hara, J, Owen, DR, Owens, D, Pacurar, M, Rampling, T, Skene, S, Winston, A, Woolley, J, Yim, YTN, Dunn, DT, McCormack, S, Shattock, RJ, COVAC 1 Study Team
وصف الملف: application/pdf
Relation: https://openaccess.sgul.ac.uk/id/eprint/115173/1/COVAC1%20phase%202a%20expanded%20safety%20and%20immunogenicity%20study%20of%20a%20self-amplifying%20RNA%20vaccine%20against%20SARS-CoV-2.pdf; Szubert, AJ; Pollock, KM; Cheeseman, HM; Alagaratnam, J; Bern, H; Bird, O; Boffito, M; Byrne, R; Cole, T; Cosgrove, CA; et al. Szubert, AJ; Pollock, KM; Cheeseman, HM; Alagaratnam, J; Bern, H; Bird, O; Boffito, M; Byrne, R; Cole, T; Cosgrove, CA; Faust, SN; Fidler, S; Galiza, E; Hassanin, H; Kalyan, M; Libri, V; McFarlane, LR; Milinkovic, A; O'Hara, J; Owen, DR; Owens, D; Pacurar, M; Rampling, T; Skene, S; Winston, A; Woolley, J; Yim, YTN; Dunn, DT; McCormack, S; Shattock, RJ; COVAC 1 Study Team (2023) COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2. EClinicalMedicine, 56. p. 101823. ISSN 2589-5370 https://doi.org/10.1016/j.eclinm.2022.101823 SGUL Authors: Cosgrove, Catherine
-
3Academic Journal
المؤلفون: Pollock, KM, Cheeseman, HM, Szubert, AJ, Libri, V, Boffito, M, Owen, D, Bern, H, O'Hara, J, McFarlane, LR, Lemm, N-M, McKay, PF, Rampling, T, Yim, YTN, Milinkovic, A, Kingsley, C, Cole, T, Fagerbrink, S, Aban, M, Tanaka, M, Mehdipour, S, Robbins, A, Budd, W, Faust, SN, Hassanin, H, Cosgrove, CA, Winston, A, Fidler, S, Dunn, DT, McCormack, S, Shattock, RJ, COVAC1 study Group
المصدر: EClinicalMedicine , 44 , Article 101262. (2022)
مصطلحات موضوعية: AEs, adverse events, GOI, gene of Interest, LNP, lipid nanoparticle, NSP, non-structural protein, VEEV, Venezuelan equine encephalitis virus, saRNA, self-amplifying RNA
وصف الملف: text
Relation: https://discovery.ucl.ac.uk/id/eprint/10142501/1/1-s2.0-S2589537021005435-main.pdf; https://discovery.ucl.ac.uk/id/eprint/10142501/
-
4Academic Journal
المؤلفون: Abraham, S, Juel, HB, Bang, P, Cheeseman, HM, Dohn, RB, Cole, T, Kristiansen, MP, Korsholm, KS, Lewis, D, Olsen, AW, McFarlane, LR, Day, S, Knudsen, S, Moen, K, Ruhwald, M, Kromann, I, Andersen, P, Shattock, RJ, Follmann, F
المساهمون: Commission of the European Communities
المصدر: 1100 ; 1091
مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Infectious Diseases, PROTECTIVE IMMUNITY, GENITAL-TRACT, TRACHOMATIS, INFECTION, Microbiology, 1103 Clinical Sciences, 1108 Medical Microbiology
جغرافية الموضوع: United States
Relation: Lancet Infectious Diseases; http://hdl.handle.net/10044/1/76146; 280873
الاتاحة: http://hdl.handle.net/10044/1/76146
https://doi.org/10.1016/S1473-3099(19)30279-8 -
5Academic Journal
المؤلفون: Cheeseman, HM, Day, S, McFarlane, LR, Fleck, S, Miller, A, Cole, T, Sousa-Santos, N, Cope, A, Cizmeci, D, Tolazzi, M, Hwekwete, E, Hannaman, D, Kratochvil, S, McKay, PF, Chung, AW, Kent, SJ, Cook, A, Scarlatti, G, Abraham, S, Combadiere, B, McCormack, S, Lewis, DJ, Shattock, RJ
Relation: NHMRC/1115828; Cheeseman, H. M., Day, S., McFarlane, L. R., Fleck, S., Miller, A., Cole, T., Sousa-Santos, N., Cope, A., Cizmeci, D., Tolazzi, M., Hwekwete, E., Hannaman, D., Kratochvil, S., McKay, P. F., Chung, A. W., Kent, S. J., Cook, A., Scarlatti, G., Abraham, S. ,. Shattock, R. J. (2018). Combined Skin and Muscle DNA Priming Provides Enhanced Humoral Responses to a Human Immunodeficency Virus Type 1 Clade C Envelope Vaccine. HUMAN GENE THERAPY, 29 (9), pp.1011-1028. https://doi.org/10.1089/hum.2018.075.; http://hdl.handle.net/11343/251150
الاتاحة: http://hdl.handle.net/11343/251150